Breyanzi CAR-T cells for Clatterbridge come from Bristol Myers Squibb
- The Clatterbridge Cancer Centre NHS Foundation Trust
- North West
- Direct
- 28 April 2026 to 29 April 2026
The Clatterbridge Cancer Centre NHS Foundation Trust bought Breyanzi CAR-T cells from Bristol Myers Squibb. Breyanzi is a CAR-T cell therapy, and the treatment was commissioned through NHS England.
The trust awarded the £140,250 order directly, and the products were to be supplied direct. Supply was set for the end of April 2026.
- What
- Medicines supply
- Supplier
- Bristol Myers Squibb
- Value
- £140,250
- How it was bought
- Direct
- Dates and next
- Apr 2026 to Apr 2026